LOGO
LOGO

Autoimmune Targets, Solid Tumor Dosing, And ALLOHA Data Keep TCRX In Focus

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
tcrx 23102025 lt

Clinical-stage biotech company TScan Therapeutics Inc. (TCRX) is emerging as an interesting biotech name to watch, with fresh momentum across both its autoimmune and oncology programs.

Company Overview

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19